Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q3 2020 Results Earnings Conference Call November 5, 2020 8:00 AM ET
Company Participants
Stephanie Carrington - IR, Westwicke
Keith Kendall - President and Chief Executive Officer
John Maxwell - SVP and Chief Financial Officer
Dan Barber - SVP and Chief Operating Officer
Ken Marshall - SVP and Chief Commercial Officer
Conference Call Participants
Gary Nachman - BMO Capital Markets
Andreas Argyrides - Wedbush
Thomas Flaten - Lake Street Capital
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Q3 2020 Aquestive Therapeutics Inc. earnings conference call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator instructions] Please be advised, that today’s conference is being recorded. [Operator Instructions]
I would now like to hand the conference over to your speaker today, Stephanie Carrington, Westwood, Investor Relations. Thank you. Please go ahead, ma'am.
Stephanie Carrington
Thank you, operator. Good morning and welcome to today's call. I'm joined by Keith Kendall, President and Chief Executive Officer, and John Maxwell, Chief Financial Officer, who will be providing an overview of recent business developments and performance of the company in the third quarter. We expect today's call to last approximately 60 minutes.
The company's remarks today correspond with the earnings release that was issued after market closed yesterday. In addition, a recording of today's call will be made available on Aquestive's website within the Investor section shortly following the conclusion of this call. This call will also include a discussion of certain non-GAAP financial measures. A reconciliation to corresponding GAAP measures can be found in yesterday's earnings release.
Before we begin, let me remind you that today's call will include forward-looking statements based on the company's current expectations. These statements reflect the company's judgment as of
- Read more current AQST analysis and news
- View all earnings call transcripts